Hyperhomocysteinemia, intima-media thickness and C677T MTHFR gene polymorphism: A correlation study in patients with cognitive impairment

Atherosclerosis

Volumn 206, Issue 1, 2009, Pages 309-313

  Gorgone, Gaetano ^a,b   Ursini, Francesca ^a   Altamura, Claudia ^a,b   Bressi, Federica ^a   Tombini, Mario ^a   Curcio, Giuseppe ^a,c   Chiovenda, Paola ^a,b   Squitti, Rosanna ^b   Silvestrini, Mauro ^d   Ientile, Riccardo ^e   Pisani, Francesco ^e   Rossini, Paolo Maria ^a,c   Vernieri, Fabrizio ^a,b  

^a UNIVERSITY CAMPUS BIO MEDICO   (Italy)

^b SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^c Casa di Cura San Raffaele   (Italy)

^d UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^e UNIVERSITY OF MESSINA   (Italy)

Author keywords

Alzheimer disease; Homocysteine; Intima media thickness IMT; MTHFR

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYTOSINE; FOLIC ACID; HOMOCYSTEIC ACID; THYMINE;

AGED; AMINO ACID BLOOD LEVEL; ARTERIAL WALL THICKNESS; ARTICLE; BIOCHEMISTRY; CARDIOVASCULAR PARAMETERS; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATIONAL STUDY; DNA POLYMORPHISM; ECHOGRAPHY; FEMALE; GENOTYPE; HETEROZYGOTE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROANGIOPATHY; NERVE CELL LESION; NEUROPSYCHOLOGICAL TEST; PHENOTYPE; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; CAROTID ARTERIES; COGNITION DISORDERS; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, SINGLE NUCLEOTIDE; TUNICA INTIMA;

EID: 69249244171     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2009.02.028     Document Type: Article

References (27)

1. van Oijen M., de Jong F.J., Witteman J.C., Hofman A., Koudstaal P.J., and Breteler MM. Atherosclerosis and risk for dementia. Ann Neurol 61 5 (2007) 403-410
2. Silvestrini M, Gobbi B, Pasqualetti P et al. Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease. Neurobiol Aging 2007;(December 10), http://dx.doi.org/10.1016/j.neurobiolaging.2007.11.008 [Epub ahead of print].
3. Seshadri S., Beiser A., Selhub J., et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med 346 7 (2002) 476-483
4. Prins N.D., Den Heijer T., Hofman A., et al. Homocysteine and cognitive function in the elderly: the Rotterdam scan study. Neurology 59 9 (2002) 1375-1380
5. Mattson M.P., and Shea T.B. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends Neurosci 26 3 (2003) 137-146
6. Ravaglia G., Forti P., Maioli F., et al. Homocysteine folate as risk factors for dementia and Alzheimer disease. Am J Clin Nutr 82 3 (2005) 636-643
7. Cappuccio F.P., Bell R., Perry I.J., et al. Homocysteine levels in men and women of different ethnic and cultural background living in England. Atherosclerosis 164 1 (2002) 95-102
8. Kelemen L.E., Anand S.S., Hegele R.A., et al. Associations of plasma homocysteine and the methylenetetrahydrofolate reductase C677T polymorphism with carotid intima media thickness among South Asian Chinese and European Canadians. Atherosclerosis 176 2 (2004) 361-370
9. Nakaso K., Yasui K., Kowa H., et al. Hypertrophy of IMC of carotid artery in Parkinson's disease is associated with L-DOPA homocysteine and MTHFR genotype. J Neurol Sci 207 1-2 (2003) 19-23
10. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., and Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 56 3 (1999) 303-308
11. Grigoletto F., Zappalà G., Anderson D.W., and Lebowitz B.D. Norms for the Mini-Mental State Examination in a healthy population. Neurology 53 2 (1999) 315-320
12. Carlesimo G.A., Caltagirone C., and Gainotti G. The Mental Deterioration Battery: normative data diagnostic reliability and qualitative analyses of cognitive impairment The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol 36 6 (1996) 378-384
13. Touboul P.J., Hennerici M.G., Meairs S., et al. Mannheim carotid intima-media thickness consensus (2004-2006). Cerebrovasc Dis 23 1 (2007) 75-80
14. Caccamo D., Condello S., Gorgone G., et al. Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia. Neuromolecular Med 6 2-3 (2004) 117-126
15. Selhub J. The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr 136 6 Suppl. (2006) 1726-1730
16. Dufouil C., Alpérovitch A., Ducros V., and Tzourio C. Homocysteine white matter hyperintensities and cognition in healthy elderly people. Ann Neurol 53 2 (2003) 214-221
17. Miller J.W., Green R., Mungas D.M., Reed B.R., and Jagust W.J. Homocysteine vitamin B6 and vascular disease in AD patients. Neurology 58 10 (2002) 1471-1475
18. Miller J.W., Green R., Ramos M.I., et al. Homocysteine and cognitive function in the Sacramento Area Latino Study on aging. Am J Clin Nutr 78 3 (2003) 441-447
19. Pacheco-Quinto J., Rodriguez de Turco E.B., DeRosa S., et al. Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels. Neurobiol Dis 22 3 (2006) 651-656
20. Honig L.S., Kukull W., and Mayeux R. Atherosclerosis and AD: analysis of data from the US National Alzheimer's Coordinating Center. Neurology 64 3 (2005) 494-500
21. den Heijer T., Vermeer S.E., Clarke R., et al. Homocysteine and brain atrophy on MRI of non-demented elderly. Brain 126 1 (2003) 170-175
22. Seshadri S., Wolf P.A., Beiser A.S., et al. Association of plasma total homocysteine levels with subclinical brain injury: cerebral volumes, white matter hyperintensity, and silent brain infarcts at volumetric magnetic resonance imaging in the Framingham Offspring Study. Arch Neurol 65 5 (2008) 642-649
23. Bisschops R.H., van der Graaf Y., Mali W.P., van der Grond J., and SMART Study Group. Elevated levels of plasma homocysteine are associated with neurotoxicity. Atherosclerosis 174 1 (2004) 87-92
24. Passaro A., Vanini A., Calzoni F., et al. Plasma homocysteine methylenetetrahydrofolate reductase mutation and carotid damage in elderly healthy women. Atherosclerosis 157 1 (2001) 175-180
25. Durga J., Verhoef P., Bots M.L., and Schouten E. Homocysteine and carotid intima-media thickness: a critical appraisal of the evidence. Atherosclerosis 176 1 (2004) 1-19
26. Kehoe P.G., and Wilcock G.K. Is inhibition of the renin-angiotensin system a new treatment option for Alzheimer's disease?. Lancet Neurology 6 4 (2007) 373-378
27. de la Torre J.C. Alzheimer's disease prevalence can be lowered with non-invasive testing. J Alzheimers Dis 14 3 (2008) 353-359